Reneo Pharmaceuticals, Inc.
RPHM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$53 | -$77 | -$52 | -$40 |
| Dep. & Amort. | $1 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $5 | $0 | $0 |
| Change in WC | $0 | $12 | $1 | -$3 |
| Other Non-Cash | -$4 | -$4 | -$1 | $1 |
| Operating Cash Flow | -$51 | -$64 | -$47 | -$38 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$231 | -$102 | -$31 |
| Inv. Sales/Matur. | $16 | $242 | $44 | $8 |
| Other Inv. Act. | $0 | $0 | -$0 | -$0 |
| Investing Cash Flow | $16 | $11 | -$58 | -$23 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $59 | $65 | $0 | $85 |
| Stock Repurch. | $0 | -$4 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $116 | $1 | $0 | $48 |
| Financing Cash Flow | $116 | $61 | $0 | $132 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $81 | $8 | -$105 | $71 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $30 | $20 | $125 | $54 |
| End Cash | $111 | $28 | $20 | $125 |
| Free Cash Flow | -$51 | -$64 | -$48 | -$38 |